{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:41:16Z","timestamp":1770831676333,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00330-017-5033-3","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T17:51:46Z","timestamp":1505152306000},"page":"506-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis"],"prefix":"10.1007","volume":"28","author":[{"given":"Matteo","family":"Renzulli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Buonfiglioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Brocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Serio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Giuseppe","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Mazzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Verucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Golfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Andreone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-795X","authenticated-orcid":false,"given":"Stefano","family":"Brillanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"5033_CR1","unstructured":"AASLD-IDSA (2017) Recommendations for testing, managing, and treating hepatitis C. Available via \nhttp:\/\/www.hcvguidelines.org\n\n. Accessed on 31 Jul 2017"},{"key":"5033_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","volume":"66","author":"EASL","year":"2017","unstructured":"EASL (2017) Recommendations on Treatment of Hepatitis C 2016. J Hepatol 66:153\u2013194","journal-title":"J Hepatol"},{"key":"5033_CR3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","volume":"52","author":"TR Morgan","year":"2010","unstructured":"Morgan TR, Ghany MG, Kim HY et al (2010) Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 52:833\u2013844","journal-title":"Hepatology"},{"key":"5033_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2016.10.017","volume":"66","author":"AJ Meer van der","year":"2017","unstructured":"van der Meer AJ, Feld JJ, Hofer H et al (2017) Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication. J Hepatol 66:485\u2013493","journal-title":"J Hepatol"},{"key":"5033_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","volume":"158","author":"RL Morgan","year":"2013","unstructured":"Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Yet F-Y (2013) Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 158:329\u2013337","journal-title":"Ann Intern Med"},{"key":"5033_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2014.02.022","volume":"61","author":"CF Huang","year":"2014","unstructured":"Huang CF, Yeh ML, Tsai PC et al (2014) Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. J Hepatol 61:67\u201374","journal-title":"J Hepatol"},{"key":"5033_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.28535","volume":"64","author":"HB El-Serag","year":"2016","unstructured":"El-Serag HB, Kanwal F, Richardson P, Kramer J (2016) Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology 64:130\u2013137","journal-title":"Hepatology"},{"key":"5033_CR8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2016.07.004","volume":"65","author":"JC Nault","year":"2016","unstructured":"Nault JC, Colombo M (2016) Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution. J Hepatol 65:663\u2013665","journal-title":"J Hepatol"},{"key":"5033_CR9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","volume":"65","author":"F Conti","year":"2016","unstructured":"Conti F, Buonfiglioli F, Scuteri A et al (2016) Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 65:727\u2013733","journal-title":"J Hepatol"},{"key":"5033_CR10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig M, Mari\u00f1o Z, Perell\u00f3 C et al (2016) Unexpected high rate of early tumour recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol 65:719\u2013726","journal-title":"J Hepatol"},{"key":"5033_CR11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850\u2013855","journal-title":"Gastroenterology"},{"key":"5033_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360","journal-title":"Semin Liver Dis"},{"key":"5033_CR13","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00330-009-1331-8","volume":"19","author":"H Kim","year":"2009","unstructured":"Kim H, Park MS, Choi JY et al (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744\u20131751","journal-title":"Eur Radiol"},{"key":"5033_CR14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.27877","volume":"62","author":"S Banerjee","year":"2015","unstructured":"Banerjee S, Wang DS, Kim HJ et al (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 62:792\u2013800","journal-title":"Hepatology"},{"key":"5033_CR15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2015150998","volume":"279","author":"M Renzulli","year":"2016","unstructured":"Renzulli M, Brocchi S, Cucchetti A et al (2016) Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology 279:432\u2013442","journal-title":"Radiology"},{"key":"5033_CR16","doi-asserted-by":"publisher","unstructured":"Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2017.04.024","DOI":"10.1016\/j.jhep.2017.04.024"},{"key":"5033_CR17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2016.06.009","volume":"65","author":"K Kozbial","year":"2016","unstructured":"Kozbial K, Moser S, Schwarzer R et al (2016) Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment. J Hepatol 65:856\u2013858","journal-title":"J Hepatol"},{"key":"5033_CR18","first-page":"10A","volume":"63","author":"A Romano","year":"2016","unstructured":"Romano A, Capra F, Piovesan S et al (2016) Incidence and pattern of \"de novo\" hepatocellular carcinoma in HCV patients treated with oral DAAs. Hepatology 63:10A","journal-title":"Hepatology"},{"key":"5033_CR19","volume":"66","author":"M Reig","year":"2017","unstructured":"Reig M, Mari\u00f1o Z, Perell\u00f3 C et al (2017) Tumour recurrence after Interferon-free treatment for hepatitis C in patients with previously treated hepatocellular carcinoma discloses a more aggressive pattern and faster tumour growth. J Hepatol 66:PS-031","journal-title":"J Hepatol"},{"key":"5033_CR20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/SLA.0b013e31821ad884","volume":"254","author":"KC Lim","year":"2011","unstructured":"Lim KC, Chow PK, Allen JC et al (2011) Microvascular invasion is a better predictor of tumour recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 254:108\u2013113","journal-title":"Ann Surg"},{"key":"5033_CR21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/TP.0000000000001606","volume":"101","author":"JM Werner","year":"2017","unstructured":"Werner JM, Adenugba A, Protzer U (2017) Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC? Transplantation 101:904\u2013909","journal-title":"Transplantation"},{"key":"5033_CR22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"EASL-EORTC","year":"2012","unstructured":"EASL-EORTC (2012) Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 56:908\u2013943","journal-title":"J Hepatol"},{"key":"5033_CR23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","volume":"65","author":"LS Belli","year":"2016","unstructured":"Belli LS, Berenguer M, Cortesi PA et al (2016) Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study. J Hepatol 65:524\u2013531","journal-title":"J Hepatol"},{"key":"5033_CR24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2016.06.023","volume":"65","author":"JD Yang","year":"2016","unstructured":"Yang JD, Aqel BA, Pungpapong S, Gores GJ, Roberts LR, Leise MD (2016) Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma. J Hepatol 65:859\u2013860","journal-title":"J Hepatol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-5033-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T04:48:28Z","timestamp":1513831708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-5033-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["5033"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-5033-3","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]}}}